2021
DOI: 10.14814/phy2.14700
|View full text |Cite
|
Sign up to set email alerts
|

Impact of synthetic surfactant CHF5633 with SP‐B and SP‐C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 56 publications
2
5
0
Order By: Relevance
“…Therefore, we assessed IL-6 and IL-8 in our study. We found similar or even higher interleukin levels in BAL compared to other animal models of ALI (26,28,(32)(33)(34). Additionally, the amount of released mediators correlates with the severity and onset of ALI.…”
Section: In Ammationsupporting
confidence: 74%
“…Therefore, we assessed IL-6 and IL-8 in our study. We found similar or even higher interleukin levels in BAL compared to other animal models of ALI (26,28,(32)(33)(34). Additionally, the amount of released mediators correlates with the severity and onset of ALI.…”
Section: In Ammationsupporting
confidence: 74%
“…The positive effects of antiinflammatory applications on the development of postoperative adhesion have also been studied. Studies in the literature show that surfactant preparations in different tissues can prevent exaggerated inflammation with the immuno-regulation process [ 32 ]. Although its effect on intestinal inflammation has not been defined concretely, the development of an organized fibrotic process associated with advanced inflammation was reduced in all groups treated with surfactant preparation in our study.…”
Section: Discussionmentioning
confidence: 99%
“…The artificial surfactant CHF5633 constitutes an interesting step forward in the development of synthetic preparations. Although various aspects still require testing, this wholly synthetic preparation containing SP-B and SP-C analogues has been shown to be as effective as Curosurf in a lamb model of ARDS and in clinical trials with preterm babies. ,,, Interestingly, the DPPC in CHF5633 was metabolized significantly more slowly in mice than was DPPC in Curosurf . This difference was attributed to the larger dose of DPPC (2.5 vs 1.75 mg/mouse), which arose because CHF 5633 contains only two PLs.…”
Section: Perspectives and Future Considerationsmentioning
confidence: 99%
“…BLES also has a similar PL profile as the starting bovine surfactant material but has most of the cholesterol removed during its preparation. Most synthetic surfactants, as exemplified in Table 1 by inclusion of the recently developed CHF5633, 62 include only 2 or 3 lipids and always contain a high percentage of DPPC. All these preparations in Table 1 contain hydrophobic surfactant proteins.…”
Section: Neonatal Respiratory Distress Syndromementioning
confidence: 99%